Categories AlphaGraphs, Earnings, Health Care

Vertex Pharmaceuticals (VRTX) Earnings: 2Q23 Key Numbers

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported product revenue of $2.49 billion for the second quarter of 2023, which was up 14% year-over-year.

Net income was $915.7 million, or $3.52 per share, compared to $810.5 million, or $3.13 per share, last year. Adjusted EPS was $3.89.

For the full year of 2023, CF product revenues are expected to range between $9.7-9.8 billion.

Prior performance

Most Popular

Infographic: How UnitedHealth Group (UNH) performed in Q1 2025

UnitedHealth Group (NYSE: UNH) reported its first quarter 2025 earnings results today. Total revenues were $109.6 billion compared to $99.8 billion in the same quarter a year ago. Net earnings

INFY Earnings: Infosys Q4 profit drops despite an increase in revenues

Infosys (NYSE: INFY) Thursday reported an increase in revenues for the fourth quarter of 2025. However, Q4 profit declined year-over-year. The software firm’s revenues increased 3.6% year-over-year to $4.73 billion

AXP Earnings: Key quarterly highlights from American Express’ Q1 2025 financial results

American Express Company (NYSE: AXP) reported its first quarter 2025 earnings results today. Consolidated total revenues net of interest expense were $17 billion, up 7% year-over-year. Revenues grew 8% on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top